<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Nagahama_Results skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Nagahama/Results</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="menu_wrapper"><DIV class="collapsable_menu_control"> MENU ▤ </DIV><UL id="accordion" class="accordion"><LI class="menu_item"><A href="https://2016.igem.org/Team:Nagahama">HOME </A></LI><LI class="menu_item"> PROJECT  
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Introduction">  ・ Introduction </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Result and Discussion"> ・ Result and Discussion </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Future"> ・ Future </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Protocol"> ・ Protocol </A></LI></UL><LI class="menu_item"> BioBricks  
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Our all BioBricks"> ・ Our all BioBricks </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/BioBricks for medal"> ・ BioBricks for medal </A></LI><LI class="menu_item"><A href="https://2016.igem.org/Team:Nagahama/Safety"> Safety </A></LI><LI class="menu_item"> Attributions
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Team">  ・Team</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Attributions"> ・Attributions </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Sponsors"> ・Sponsors</A></LI><LI class="menu_item"> Collaborations
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Collaborations">  ・Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/The Annual Meeting Of The Genetics Society Of Japan"> ・The Annual Meeting Of The Genetics Society Of Japan </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Support Gifu"> ・Support Gifu</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/virginia"> ・ Virginia</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Paris-Saclay"> ・ Paris-Saclay</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Munich United"> ・Munich United</A></LI><LI class="menu_item"> Human Practice
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Human Practice">・ Human Practice </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Contacting Local"> ・Contacting Local</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Contacting Japan"> ・Contacting Japan</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Intgrated Human Practice"> ・Intgrated Human Practice</A></LI><LI class="menu_item"><A href="https://2016.igem.org/Team:Nagahama/Proof of concept"> Proof of concept </A></LI><LI class="menu_item"><A href="https://2016.igem.org/Team:Nagahama/Demonstrate your work"> Demonstrate your work </A></LI></DIV><DIV class="content_wrapper"><H1><SPAN class="mw-headline" id="Result">Result</SPAN></H1><H2><SPAN class="mw-headline" id="Enhancement_of_farnesol_resistance">Enhancement of farnesol resistance</SPAN></H2><DIV class="thumb tleft"><DIV class="thumbinner" style="width:752px;"><DIV class="thumbcaption">Fig. ?: Colony formation efficiencies of <I>E. coli</I> JM109 engineered with <I>marA</I> on geraniol overlaid plates.  <I>E. coli</I> JM109 and <I>E. coli</I> JM109 (<I>marA</I>) were spotted on LBGMg agar plates in serial ten-fold dilutions (10⁻¹～10⁻6), overlaid with 30.0 % (v/v)　fanesol hexane solution (farnesol solution), and incubated at 30°C for 24 h. This figure shows that <I>E. coli</I> JM109 (<I>marA</I>) cells that overexpress the <I>marA</I> product is more survived on 30.0 % farnesol solution overlay plates than the counterpart control <I>E. coli</I> JM109  wild type cells.</DIV></DIV></DIV><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:182px;"><A href="/File:MarA_plate_assay_nishikawa_last_2.png" title="File:MarA plate assay nishikawa last 2.png">File:MarA plate assay nishikawa last 2.png</A><DIV class="thumbcaption">Fig. 14: Comparison of colony numbers after addition of 0.5 %( v/v) geraniol hexane solution (geraniol solution).   Time interval for treatment was set every 1 hour from 1 hour to 4 hours. A: <I>E. coli</I> JM109 (WT) + hexane; B: <I>E. coli</I> JM109 (<I>marA</I>) + hexane; C: <I>E. coli</I> JM109 (WT) + 0.5 % geraniol solution; D: <I>E. coli</I> JM109 (<I>marA</I>) + 0.5 % geraniol solution. As shown in Figs. 14 A and B, treatment with hexane of <I>E. coli</I> JM109 (WT) and of <I>E. coli</I> JM109 (<I>marA</I>) showed similar colony numbers during these treatment intervals to those of time zero. This result suggests that hexane at this concentration and duration of time for 4hours did not affect both cell growth. In contrast, treatment with geraniol of <I>E. coli</I> JM109 (WT) and of <I>E. coli</I> JM109 (<I>marA</I>) showed toxicities to both strains (Figs. 14 B, C and D). If we watch the colony numbers carefully, <I>E. coli</I> JM109 (<I>marA</I>) had more than <I>E. coli</I> JM109 (WT) during these treatment intervals ((Figs. 14 C and D). These results demonstrate that toxicity of the geraniol was less to the strain <I>E. coli</I> JM109 (<I>marA</I>) than the strain <I>E. coli</I> JM109 (WT).</DIV></DIV></DIV></DIV><DIV class="thumb tleft"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption"><I>Fig.The result of RT-PCR</I>                  Lane1:100bp DNA ladder    Lane2:dxs(WT)  Lane3:dxs(MEP)  Lane4:idi(WT)  Lane5:idi(MEP)  Lane6:ispA(WT)  Lane7:ispA(MEP)  Lane8:ispD(WT)  Lane9:ispD(MEP)  Lane10:GES(WT)  Lane11:GES(GES)  Lane12:gapA(WT)  Lane13:gapA(MEP)  Lane14:gapA(GES)</DIV></DIV></DIV><DIV class="thumb tnone"><DIV class="thumbinner" style="width:372px;"><DIV class="thumbcaption"><I>Fig.The result of RT-PCR Negative control</I> Lane1:dxs(WT)  Lane2:dxs(MEP)  Lane3:idi(WT)  Lane4:idi(MEP)  Lane5:ispA(WT)  Lane6:ispA(MEP)  Lane7:ispD(WT)  Lane8:ispD(MEP)  Lane9:GES(WT)  Lane10:GES(GES)  Lane11:gapA(WT)  Lane12:gapA(MEP)  Lane13:gapA(GES)</DIV></DIV></DIV><P>
We reinforced by overexpressing genes that dxs,idi,ispD and ispF, which was the bottom neck of MEP route. GC-MS detected synthetic amount of farnesol was very low. We checked amount of transcription by RT-PCR and q-PCR. 
</P><H2><SPAN class="mw-headline" id="temp">temp</SPAN></H2><P>Here you can describe the results of your project and your future plans.
What should this page contain?
Clearly and objectively describe the results of your work.
Future plans for the project
Considerations for replicating the experiments
Project Achievements
You can also include a list of bullet points (and links) of the successes and failures you have had over your summer. It is a quick reference page for the judges to see what you achieved during your summer.
A list of linked bullet points of the successful results during your project
A list of linked bullet points of the unsuccessful results during your project. This is about being scientifically honest. If you worked on an area for a long time with no success, tell us so we know where you put your effort.
Inspiration
See how other teams presented their results.
2014 TU Darmstadt
2014 Imperial
2014 Paris Bettencourt
</P></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>